Daniel A. Harki, Ph.D.

Daniel HarkiAssociate Professor
       Department of Medicinal Chemistry
       Department of Chemistry (affiliated)
       Department of Biochemistry, Molecular Biology & Biophysics (affiliated)
Member, Masonic Cancer Center
Faculty, Stem Cell Institute

Curriculum Vitae (pdf download)
Google Scholar Profile

Educational Background

Postdoctoral Scholar in Chemistry, California Institute of Technology (2005-2009)

Ph.D. in Chemistry, The Pennsylvania State University (2005)

B.A. in Biology & Chemistry (double major, magna cum laude), West Virginia University (1999)


Professional Appointments

Present- Associate Professor of Medicinal Chemistry (tenured), University of Minnesota (UMN), Minneapolis, MN (2016-present).

Secondary UMN Appointments

  • Graduate Faculty, Department of Chemistry (2016-present)
  • Graduate Faculty, Department of Biochemistry, Molecular Biology & Biophysics (2014-present)
  • Faculty, Stem Cell Institute (2014-present)
  • Member, Masonic Cancer Center (2009-present)

President & CEO, D.A. Harki Consulting, LLC (2016 – present)

Co-Founder, Consultant and Shareholder, ApoGen Biotechnologies, Inc., Seattle, WA (2014 – present) www.apogenbiotech.com

Co-Founder, ApoGen Biotechnologies, LLC, St. Paul, MN (2011 – 2014)

Assistant Professor of Medicinal Chemistry, University of Minnesota, Minneapolis, MN (2009 – 2016)

Postdoctoral Scholar in Chemistry, California Institute of Technology, Division of Chemistry and Chemical Engineering (2005 – 2009)

Research: Development of [18F]-fluorine-labeled pyrrole-imidazole polyamides for in vivo imaging by positron emission tomography. New methods for polyamide synthesis. Advisor: Professor Peter B. Dervan

Graduate Research in Chemistry, The Pennsylvania State University, Department of Chemistry (1999 – 2005)

Thesis: Chemical synthesis of base-modified ribonucleosides as novel antiviral agents. Advisor: Professor Blake R. Peterson

Undergraduate Research in Chemistry, West Virginia University, Department of Chemistry (1998 – 1999)

Research: Synthesis of illudin analogues. Advisor: Professor Kay M. Brummond

Biological Science Laboratory Technician, Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), Morgantown, WV (1997 – 1999)

Research: Immunotoxicology studies of arsenic exposure. Supervisor: Dr. Michael I. Luster

Awards and Honors

2016 - Inductee, Rho Chi Pharmacy Honor Society, Mu Chapter

2013 - Professor of the Semester, University of Minnesota, College of Pharmacy, Class of 2017 - Duluth

2012 – 2014 - V Foundation V Scholar, The V Foundation for Cancer Research

2012 - Hyundai Hope on Wheels Day (September 21, 2012) Proclaimed by MN Governor Mark Dayton in recognition of grant awards to DAH and another investigator at the Mayo Clinic

2007 – 2009 - California Tobacco-Related Disease Research Program, Postdoctoral Fellowship

2006 – 2007 - Friedreich's Ataxia Research Alliance, Postdoctoral Fellowship

2003 - Braucher Fellowship, The Pennsylvania State University, Department of Chemistry

2002 – 2005 - American Heart Association, Predoctoral Fellowship

2001 - Dalalian Fellowship, The Pennsylvania State University, Department of Chemistry

1999 - Phi Beta Kappa, Alpha of West Virginia, West Virginia University

1998 - Henry W. Hurlbutt Memorial Research Award, West Virginia University, Department of Biology